Animal Gastroesophageal Reflux Disease Market Forecast 2026–2035: How to Leverage Market Growth
Uncover key drivers, emerging technologies, and competitive movements shaping the aluminum bottles market from 2026–2035 with trusted insights from The Business Research Company
What is the expected shift in the Animal Gastroesophageal Reflux Disease Market’s size between 2026 and 2030?
The market size for animal gastroesophageal reflux disease has experienced significant growth over recent years. This market is projected to expand from $1.98 billion in 2025 to $2.16 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 8.8%. Historically, this growth has been influenced by factors such as veterinarians’ limited understanding of animal GERD, the widespread occurrence of GERD in companion animals, insufficient advanced diagnostic tools in veterinary hospitals, the dependence on generic drugs, and the increasing number of veterinary clinics and hospitals.
The animal gastroesophageal reflux disease market size is projected to experience substantial growth in the coming years, with expectations to reach $2.99 billion in 2030, expanding at a compound annual growth rate (CAGR) of 8.5%. This growth throughout the forecast period is driven by factors such as the development of advanced diagnostic techniques like endoscopy and manometry, a growing emphasis on nutritional and dietary interventions, the increasing adoption of both over-the-counter and prescription drugs, the expansion of veterinary e-commerce channels, and the integration of AI and digital platforms to provide personalized treatment. Major trends anticipated in this period include a rising use of endoscopy and pH monitoring for GERD diagnosis, an increased application of nutritional supplements and dietary modifications in its management, a broader availability of prescription and OTC medications for companion animals, the expansion of minimally invasive surgical interventions for GERD treatment, and the development of customized treatment protocols for livestock and companion animals.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20464&type=smp
Which Drivers Are Shaping Strategic Decisions In The Animal Gastroesophageal Reflux Disease Market?
The rising trend of pet humanization is anticipated to boost expansion within the animal gastroesophageal reflux disease market. This humanization of pets describes a developing pattern where individuals consider their animal companions as members of their own families, assigning them human-like feelings, requirements, and actions. The deepening emotional connections between owners and their pets fuel this inclination towards humanizing animals, which in turn elevates the need for specialized medical care, high-quality diets, and wellness items comparable to those for humans. Furthermore, pet humanization enhances understanding of health conditions like gastroesophageal reflux disease (GERD), motivating more vigilant owners to pursue veterinary attention and thereby increasing the need for diagnostic tools, therapies, and preventative measures. For instance, in April 2024, according to the American Pet Products Association, a US-based not-for-profit industry association, 86.9 million households in the US had a pet in 2023-2024, accounting for 66% of households, up from 62% in 2022. Consequently, the increasing humanization of pets is accelerating the growth of the animal gastroesophageal reflux disease market.
What Segment Classifications Make Up The Animal Gastroesophageal Reflux Disease Market?
The animal gastroesophageal reflux disease market covered in this report is segmented –
1) By Product: Treatment, Diagnostics
2) By Mode: Over-The-Counter (OTC), Prescription
3) By Route Of Administration: Oral, Injectable
4) By Animal: Companion Animals, Livestock Animal
5) By Distribution Channel: Veterinary Hospitals And Clinics, Retail Pharmacies, E-Commerce
Subsegments:
1) By Treatment: Medications, Surgical Interventions, Dietary Modifications, Nutritional Supplements, Antacids
2) By Diagnostics: Endoscopy, Esophageal pH Monitoring, Manometry, Ultrasound, Radiographic Studies, Biopsy Techniques
What Long-Term Trends Are Expected To Shape The Future Of The Animal Gastroesophageal Reflux Disease Market?
Major companies active in the animal gastroesophageal reflux disease market are creating specific diets that aid gastrointestinal health to enhance digestive function and alleviate symptoms of gastroesophageal reflux disease in pets. Gastrointestinal support diets represent precisely formulated pet foods intended to manage and reduce the indicators of gastrointestinal disorders. These diets usually contain ingredients that are easily digestible, balanced nutrients, and additional fibers or probiotics to support digestive well-being and general health. For instance, in April 2024, Royal Canin, a USA-based subsidiary of Mars Incorporated and a manufacturer of cat and dog food, broadened its veterinary gastrointestinal (GI) product line by introducing five new diets aimed at improving the gastrointestinal health of pets. These specialized diets, developed through cooperation with researchers, veterinarians, and specialists, concentrate on addressing GI problems in both dogs and cats, including sensitivities responsive to food and fat-restricted dietary needs. The new offerings include varieties such as gastrointestinal low-fat, hydrolyzed protein canine, and gastrointestinal hydrolyzed protein feline, all made with highly digestible components to encourage sustained gastrointestinal health.
Which Major Firms Are Strengthening Their Position In The Animal Gastroesophageal Reflux Disease Market?
Major companies operating in the animal gastroesophageal reflux disease market are Zoetis Inc., VCA Animal Hospitals, Petco Health and Wellness Company Inc., Merck Animal Health, Boehringer Ingelheim Animal Health, Elanco Animal Health Incorporated, Hill’s Pet Nutrition Inc., IDEXX Laboratories Inc., Ceva Santé Animale, Virbac S.A., Phibro Animal Health Corporation, Dechra Pharmaceuticals PLC, Blue Buffalo Company Ltd., Vetoquinol S.A., Antech Diagnostics, Heska Corporation, WellPet LLC, McNeil Consumer Pharmaceuticals Co., Wag Labs Inc. , VetPartners Limited, BioZyme Inc., Zomedica Corp., NexGen Pharmaceuticals LLC
Access The Complete Report For Deeper Market Insights:
Which Region Is Anticipated To See The Fastest Growth In The Animal Gastroesophageal Reflux Disease Market?
North America was the largest region in the animal gastroesophageal reflux disease market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the animal gastroesophageal reflux disease market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Animal Gastroesophageal Reflux Disease Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=20464&type=smp
Browse Through More Reports Similar to the Global Animal Gastroesophageal Reflux Disease Market 2026, By The Business Research Company
Gastroesophageal Reflux Disease Therapeutics Global Market Report 2026
Animal Therapeutics And Diagnostics Global Market Report 2026
Animal Biotechnology Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/animal-biotechnology-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
